Fulminant Hepatitis Associated With Echovirus 25 During Treatment With Ocrelizumab for Multiple Sclerosis-Reference-Cited by-同舟云学术

Fulminant Hepatitis Associated With Echovirus 25 During Treatment With Ocrelizumab for Multiple Sclerosis

Published:2019-07-01 Issue:7 Volume:76 Page:866
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Nicolini Laura Ambra¹²,Canepa Paola¹,Caligiuri Patrizia¹,Mikulska Malgorzata¹²,Novi Giovanni³,Viscoli Claudio¹²,Uccelli Antonio³⁴

Affiliation:

1. Department of Health Sciences, University of Genoa, Genoa, Italy

2. Infectious Diseases Unit, Ospedale Policlinico San Martino–Istituto Di Ricovero e Cura a Carattere Scientifico, Genoa, Italy

3. Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health and Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy

4. Ospedale Policlinico San Martino–Istituto Di Ricovero e Cura a Carattere Scientifico, Genoa, Italy

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

http:///jamaneurology/article-pdf/76/7/866/17684601/jamaneurology_nicolini_2019_ld_190001.pdf

Reference6 articles.

1. Severe hepatitis associated with an echovirus 18 infection in an immune-compromised adult.;Lefterova;J Clin Microbiol,2013

2. A case of fulminant hepatitis due to echovirus 9 in a patient on maintenance rituximab therapy for follicular lymphoma.;Morgan;Case Rep Hematol,2015

3. Acute liver failure due to echovirus 9 associated with persistent B-cell depletion from rituximab.;Bajema;Open Forum Infect Dis,2017

4. Enteroviral infection in patients treated with rituximab for non-Hodgkin lymphoma: a case series and review of the literature.;Grisariu;Hematol Oncol,2017

5. Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis.;Hauser;N Engl J Med,2017

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe enterovirus infections in patients with immune-mediated inflammatory diseases receiving anti-CD20 monoclonal antibodies;RMD Open;2024-05

2. The course of COVID-19 in a multiple sclerosis: a case report;Wiadomości Lekarskie;2024-01

3. Histologic manifestations of ocrelizumab‐associated intestinal and hepatic injury in patients with multiple sclerosis;Histopathology;2023-12-19

4. Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System;Pharmaceuticals;2023-07-27

5. Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype Susceptibility;International Journal of Molecular Sciences;2023-01-03